Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_17-cv-04102/USCOURTS-cand-3_17-cv-04102-1/pdf.json

Nature of Suit Code: 850
Nature of Suit: Securities, Commodities, Exchange
Cause of Action: 15:78m(a) Securities Exchange Act

---

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

STIPULATION AND ORDER GOVERNING CASE MANAGEMENT SCHEDULING ORDER CASE NO. 

3:17-CV-04102 

Pamela S. Palmer (SBN 107590) 

E-mail: palmerp@pepperlaw.com

Kevin A. Crisp (SBN 261023) 

E-mail: crispk@pepperlaw.com

PEPPER HAMILTON LLP 

350 South Grand Avenue 

Two California Plaza, Suite 3400 

Los Angeles, CA 90071 

Telephone: 213.928.9818 

Fax: 213.928.9850 

M. Duncan Grant (Admitted Pro Hac Vice)

E-mail: grantm@pepperlaw.com

Christopher B. Chuff (Admitted Pro Hac Vice) 

E-mail: chuffc@pepperlaw.com

PEPPER HAMILTON LLP 

Hercules Plaza, Suite 5100 

1313 Market Street, Suite 5100 

Wilmington, DE 19899 

Telephone: 302.777.6500 

Attorneys for Defendants Jaguar Animal Health, Inc., 

Jaguar Health, Inc., James J. Bochnowski, Lisa Conte, 

John Micek III, and Ari Azhir 

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA – SAN FRANCISCO DIVISION 

TONY PLANT, Individually and on Behalf 

of All Others Similarly Situated, 

Plaintiff, 

v. 

JAGUAR ANIMAL HEALTH, INC., 

JAMES J. BOCHNOWSKI, LISA CONTE, 

JOHN MICEK III, and ARI AZHIR, 

Defendants. 

Case No. 3:17-cv-04102 

Assigned for all purposes to the Honorable 

Richard Seeborg 

STIPULATION GOVERNING CASE 

MANAGEMENT SCHEDULING ORDER 

DEADLINES AND ORDER 

Case 3:17-cv-04102-RS Document 75 Filed 04/10/20 Page 1 of 5
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

-1-

STIPULATION AND ORDER GOVERNING CASE MANAGEMENT SCHEDULING ORDER CASE NO. 

3:17-CV-04102 

WHEREAS, this case was filed as a putative class action on July 20, 2017 by an 

alleged stockholder of Jaguar Animal Health, Inc. (“Jaguar”), alleging violation of Section 14(a) 

and Section 20(a) of the Securities Exchange Act of 1934 and related regulations with respect to 

disclosures in a Joint Proxy Statement and Prospectus (“Joint Proxy”) soliciting stockholder 

approval of a merger with Napo Pharmaceuticals, Inc. 

WHEREAS, after the merger closed on July 31, 2017, the plaintiff moved to be 

appointed as lead plaintiff for the putative class and for appointment of his attorneys as lead 

counsel pursuant to the Private Securities Litigation Reform Act (“PSLRA”), 15 U.S.C. § 78u4(a)(3)(B). On December 11, 2017, the Court granted plaintiff’s unopposed motion without a 

hearing. 

WHEREAS, on January 10, 2018, the plaintiff filed an Amended Class Action 

Complaint asserting the same two securities law claims, adding certain allegations and dropping 

three initially named defendants, all of whom reside overseas. 

WHEREAS, on October 10, 2018, the plaintiff filed a Second Amended Class 

Action Complaint, asserting the same two securities law claims and adding certain allegations. 

The defendants intend to move to dismiss the Second Amended Class Action Complaint for 

failure to state a claim upon which relief may be granted. The Court denied the motion to dismiss 

on June 28, 2019. 

WHEREAS, on July 18, 2019, the Court entered the Case Management 

Scheduling Order setting deadlines for the case. 

WHEREAS, in March and April 2020, and most likely for at least several 

additional months in the future, the nation has grappled with the COVID-19 crisis, which has 

impeded the progress of this litigation, including the ability to take in-person depositions. 

WHEREAS, the parties have begun discussing a potential settlement of this 

matter. 

Case 3:17-cv-04102-RS Document 75 Filed 04/10/20 Page 2 of 5
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

-2-

STIPULATION AND ORDER GOVERNING CASE MANAGEMENT SCHEDULING ORDER CASE NO. 

3:17-CV-04102 

WHEREAS, under those circumstances, it would be beneficial to the appropriate 

use of the Court’s and the parties’ resources to extend the deadlines that are set forth in the Case 

Management Scheduling Order. 

WHEREFORE, the parties hereby stipulate and agree to the following changes to 

the Case Management Scheduling Order: 

DISCOVERY 

• On or before December 18, 2020 (previously June 26, 2020), all non-expert

discovery shall be completed by the parties;

EXPERT WITNESSES 

• On or before January 29, 2021 (previously July 31, 2020), parties will designate

experts in accordance with Federal Rule of Civil Procedure 26(a)(2);

• On or before February 26, 2021 (previously August 28, 2020), parties will

designate their supplemental and rebuttal experts in accordance with Federal Rule

of Civil Procedure 26(a)(2);

• On or before March 26, 2021 (previously September 25, 2020), all discovery of

expert witnesses pursuant to Federal Rule of Civil Procedure 26(b)(4) shall be

completed;

CLASS CERTIFICATION 

• On or before April 9, 2021 (previously October 9, 2020), plaintiff will file his

motion for class certification;

• On or before May 7, 2021 (previously November 6, 2020), defendant will file its

opposition to class certification;

• On or before May 21, 2021 (previously November 20, 2020), plaintiff will file his

reply, if any, to defendant’s opposition.

{signatures on next page} 

Case 3:17-cv-04102-RS Document 75 Filed 04/10/20 Page 3 of 5
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

-3-

STIPULATION AND ORDER GOVERNING CASE MANAGEMENT SCHEDULING ORDER CASE NO. 

3:17-CV-04102 

DATED: April 9, 2020 MONTEVERDE & ASSOCIATES PC 

By: /s/ David E. Bower___________________ 

David E. Bower 

600 Corporate Pointe, Suite 1170 

Culver City, CA 90230 

Telephone: 213/446-6652 

Fax: 212/202-7880 

-andJuan E. Monteverde 

The Empire State Building 

350 Fifth Avenue, Suite 4405 

New York, New York 10118 

Tel: 212-971-1341 

Fax: 212-202-7880 

Attorneys for Plaintiff Tony Plant and the 

Proposed Class 

DATED: April 9, 2020 PEPPER HAMILTON LLP 

By: /s/ Pamela S. Palmer___________________ 

Pamela S. Palmer 

M. Duncan Grant (grantm@pepperlaw.com)

Christopher B. Chuff (chuffc@pepperlaw.com)

1313 Market Street, Suite 5100

Wilmington, Delaware 19899

Tel: (302) 777- 6544

-andPamela S. Palmer (palmerp@pepperlaw.com) 

Kevin Crisp (crispk@pepperlaw.com) 

350 South Grand Avenue

Two California Plaza, Suite 3400

Los Angeles, CA 90071 

Tel: (213) 928-9814 

Attorney for Defendants Jaguar Animal Health, Inc., 

James J. Bochnowski, Lisa Conte, John Micek III, 

and Ari Azhir 

Case 3:17-cv-04102-RS Document 75 Filed 04/10/20 Page 4 of 5
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

-4-

STIPULATION AND ORDER GOVERNING CASE MANAGEMENT SCHEDULING ORDER CASE NO. 

3:17-CV-04102 

ORDER 

The parties’ Stipulation Governing Case Management Scheduling 

Order Deadlines is GRANTED. 

The hearing for plaintiff’s motion for class certification is continued 

from December 17, 2020 to __________________ at _____ in the United States 

District Court for the Northern District of California, at 450 Golden Gate Avenue, 

San Francisco, California 94102, Courtroom 3, 17th Floor. 

IT IS SO ORDERED. 

Dated:

The Honorable Richard Seeborg 

Judge of the United States District Court 

for the Northern District of California 

June 10, 2021 1:30 pm

4/10/2020

Case 3:17-cv-04102-RS Document 75 Filed 04/10/20 Page 5 of 5